Denosumab Biosimilar, Human IgG1. Denosumab biosimilar CHO stable cell line is available for licensing to manufacture the denosumab biosimilar protein.The research grade denosumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype...
Denosumab Biosimilar, N297A Mutant. Denosumab biosimilar CHO stable cell line is available for licensing to manufacture the denosumab biosimilar protein.The research grade denosumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype...
Denosumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Denosumab biosimilar CHO stable cell line is available for licensing to manufacture the denosumab biosimilar protein.The research grade denosumab biosimilar protein is for research use only...
Bevacizumab Biosimilar, N297A Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Bevacizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only...
Adalimumab Biosimilar, N297A Mutant. Adalimumab biosimilar CHO stable cell line is available for licensing to manufacture the adalimumab biosimilar protein.The research grade adalimumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
